Insider Transactions in Q2 2025 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2025
|
Joseph Vittiglio Chief Business & Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,625
-100.0%
|
-
|
|
Jun 02
2025
|
Joseph Vittiglio Chief Business & Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Jun 02
2025
|
John O Agwunobi |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
Najoh Tita Reid |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
Richard A Colvin Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,666
-100.0%
|
-
|
|
Jun 02
2025
|
Richard A Colvin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Jun 02
2025
|
Mark Vachon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
Andrew Obenshain President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,120
-100.0%
|
-
|
|
Jun 02
2025
|
Andrew Obenshain President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,820
+50.0%
|
-
|
|
Jun 02
2025
|
Elisabeth Leiderman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
O. James Sterling Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-100.0%
|
-
|
|
Jun 02
2025
|
O. James Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Jun 02
2025
|
Thomas J Klima |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,964
-100.0%
|
-
|
|
Jun 02
2025
|
Thomas J Klima |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
|
Jun 02
2025
|
Charlotte Jones Burton |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
Nick Leschly |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,245
-100.0%
|
-
|
|
Jun 02
2025
|
Michael Cloonan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,867
-100.0%
|
-
|
|
Jun 02
2025
|
Richard A. Paulson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,323
-100.0%
|
-
|
|
May 30
2025
|
Joseph Vittiglio Chief Business & Legal Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,143
-26.78%
|
-
|
|
May 30
2025
|
John O Agwunobi |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,323
-51.52%
|
-
|
|
May 30
2025
|
Najoh Tita Reid |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,163
-48.3%
|
-
|
|
May 30
2025
|
Richard A Colvin Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,552
-46.02%
|
-
|
|
May 30
2025
|
Mark Vachon |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,252
-50.14%
|
-
|
|
May 30
2025
|
Andrew Obenshain President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,027
-49.26%
|
-
|
|
May 30
2025
|
Elisabeth Leiderman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,112
-47.18%
|
-
|
|
May 30
2025
|
Thomas J Klima |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,414
-43.34%
|
-
|
|
May 30
2025
|
Charlotte Jones Burton |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
928
-42.71%
|
-
|
|
May 30
2025
|
Nick Leschly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
8,434
-100.0%
|
-
|
|
May 30
2025
|
Nick Leschly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,416
-92.05%
|
-
|
|
May 30
2025
|
Richard A. Paulson |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
155
-10.49%
|
-
|